Written by world experts, this books follows upon the monumental success of the first edition of The Parathyroids, which was universally acclaimed as the best text on the subject. An authoritative reference that spans the basic science of parathyroid hormone treatment to major clinical disorders in a superb, single compendium, The Parathyroids offers an objective and authoritative view on controversial clinical issues in this rapidly changing field. Every medical school library and virtually every major hospital library will need this book as a reference for students and clinicians.

Key Features

* Offers objective and authoritative reviews on controversial clinical issues

* Written by world experts on parathyroid hormone and its disorders

* Superb, state-of-the-art compendium in one convenient volume

* Bridges basic science of parathyroid hormone to major clinical disorders

* Practical information on clinical management of parathyroid hormone disorders

This reference for students, teachers, practitioners, and investigators in endocrinology presents current knowledge of the parathyroids and the clinical disorders associated with dysfunction of these glands. Following nine chapters devoted to basic concepts, coverage includes physiological aspects of calcium metabolism and the anabolic and catabolic effects of PTH at the level of bone and bone cells, clinical aspects of primary hyperparathyroidism, the parathyroids in renal disease, special considerations, hypoparathyroid states, and the role of parathyroid function in osteoporosis. This second edition reflects insights gained from researcher over the past seven years. Bilezikian is professor of medicine and pharmacology and chief of the Division of Endocrinology at the College of Physicians and Surgeons, Columbia University.
Annotation c. Book News, Inc., Portland, OR (booknews.com)

"...a comprehensive source of information that most endocrinologists will want to have on their bookshelves."

-TRENDS IN ENDOCRINOLOGY AND METABOLISM (April 2003)

Dr. Bilezikian, Professor of Medicine and Pharmacology at the College of Physicians and Surgeons, Columbia University is the Chief of the Division of Endocrinology and Director of the Metabolic Bone Diseases Program at Columbia-Presbyterian Medical Center. He also serves as Associate Chair, Department of Medicine.

Dr. Bilezikian received his undergraduate training at Harvard College and his medical training at the College of Physicians and Surgeons. He completed four years of house staff training (internship and residency) including the Chief Medical Residency of the Medical Service at Columbia Presbyterian Medical Center. Dr. Bilezikian received his training in Metabolic Bone Diseases and in Endocrinology at the NIH where he served as a Clinical Associate in the Mineral Metabolism Branch under the tutelage of Dr. Gerald Aurbach.

Dr. Bilezikian belongs to a number of professional societies, including the American Society for Bone and Mineral Research, of which he served as President in 1996. He is a member of the Endocrine Society, the American Federation for Clinical Research, the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Clinical Endocrinologists, the American Society for Pharmacology and Experimental Therapeutics, and the International Society of Clinical Densitometry, of which he is President.

He is Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism. His books include Editor-in-Chief of The Parathyroids (1994), and co-editor of Principles of Bone Biology (1996), The Aging Skeleton (1999), and Dynamics of Bone and Cartilage Metabolism (1999). He has been on numerous panels, including serving as Chair of the NIH Consensus Development Panel on Optimal Calcium Intake, and the Food and Nutrition Board of the National Academy of Sciences. He is a major national and international spokesperson for the field of metabolic bone diseases. Dr. Bilezikian's major research interests are related to the clinical investigation of metabolic bone diseases, particularly osteoporosis and primary hyperparathyroidism. His is the recipient of the Distinguished Physician Award of the Endocrine Society and of the Frederic C. Bartter Award of the American Society for Bone and Mineral Research for Excellence in the Clinical Research. He also has an active laboratory program in the biochemical mechanisms of the hormones that regulate calcium metabolism. His publications, which number of 350, speak to his active original investigative initiatives as well as his demand as an author of many reference sources of endocrinology and metabolic bone diseases.

lar features

Treatment of Hypoparathyroidism

The Parathyroids in Osteoporosis

Parathyroid Function in the Normal Aging Process

Parathyroid Function and Responsiveness in Osteoporosis

Parathyroid Hormone and Growth Hormone in the Treatment of Osteoporosis